Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Psychiatry|March 4, 2008
A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorderRobert L Findling, Oscar G Bukstein, Raun D Melmed, et al.Neuropharmacology|November 30, 2004
The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosisKevin Carter, Jon Dickerson, Darryle D Schoepp, et al.Journal of Attention Disorders|April 11, 2024
A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical TrialsValerie K Arnold, Frank A López, Ann C Childress, et al.Brain : a Journal of Neurology|June 9, 2006
Dopamine transporter genotype influences the physiological response to medication in ADHDDonald L Gilbert, Zhewu Wang, Floyd R Sallee, et al.Journal of the American Academy of Child and Adolescent Psychiatry|January 10, 2008
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysisW Burleson Daviss, Nick C Patel, Adelaide S Robb, et al.Amino Acids|June 26, 2010
Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimersAnne-Marie Estes, Kathleen McAllen, Michael S Parker, et al.Journal of Attention Disorders|June 4, 2021
Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release MethylphenidateTimothy E Wilens, Stephen V Faraone, Paul G Hammerness, et al.Journal of Child Neurology|January 14, 2014
Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD)Tina H Chen, Steve W Wu, Jeffrey A Welge, et al.Journal of Child and Adolescent Psychopharmacology|August 30, 2019
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across SettingsAnn C Childress, Andrew J Cutler, Andrea Marraffino, et al.Journal of Clinical Psychopharmacology|July 16, 2008
Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation studyRobert L Findling, Ralph E Kauffman, Floyd R Sallee, et al.Pageof 7